Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution
- PMID: 41692116
- DOI: 10.1016/j.jaci.2026.02.002
Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution
Abstract
Background: Haploinsufficiency of A20 (HA20) is an immune dysregulation disorder caused by loss-of-function TNFAIP3 mutations. This international multicenter study aimed to delineate its clinical spectrum, genetic basis, and natural history.
Methods: A cross-sectional retrospective analysis was conducted in HA20 patients with pathogenic or likely pathogenic TNFAIP3 variants. Clinical, laboratory, and treatment data were assessed. Clustering analysis was applied to evaluate clinical features and disease phenotypes. Patients were stratified by age (<16 years vs ≥16 years), country of origin (China vs United States), and sex.
Results: A total of 185 patients from 41 clinics across 7 countries were included (median age at onset, 3.3 years). Common clinical features were mucocutaneous involvement (80.5%), recurrent fever (63.3%), gastrointestinal symptoms (58.6%), cytopenia (56.6%), arthritis/arthralgia (46.7%), and recurrent infections (35.5%). Compared with adults and patients from the US cohort, intestinal ulcers were significantly more frequent in children and patients from the Chinese cohort (P = .002 and P < .0001, respectively), whereas uveitis was less common in these groups (P = .001 and P < .0001, respectively). Hierarchical clustering of clinical disease phenotypes based on Pearson distance identified two major clusters, an autoinflammation-predominant phenotype and an autoimmune-predominant phenotype. The autoinflammation-predominant phenotype was more common in children and patients from the Chinese cohort (P = .033 and .003, respectively). A total of 89 pathogenic TNFAIP3 mutations were identified, including 46 novel variants. Large deletions were associated with neurologic disease and developmental delay (P = .0054 and .0245, respectively); however, there were no clear associations between disruptions of specific functional A20 domains and age at onset or phenotype. Therapeutically, TNF and IL-1 inhibitors were effective in most patients, with thalidomide and JAK inhibitors provided in refractory cases; 51.5% had obtained minimal disease activity at most recent follow-up.
Conclusions: HA20 is a common dominantly inherited immune dysregulation disorder with phenotypic heterogeneity and potential age-dependent evolution. This large international cohort highlights diagnostic and therapeutic strategies to advance evaluation and management of HA20.
Keywords: Haploinsufficiency of A20; TNFAIP3; autoimmunity; autoinflammation.
Copyright © 2026 American Academy of Allergy, Asthma & Immunology. All rights reserved.
Conflict of interest statement
Disclosure statement T.H. received grant SZTP05202501005 from Special Support Program for High-level Talents in Shenzhen Health System and grant 82302056 from the National Natural Science Foundation of China. Q.Z. received grants 82225022, 32141004 and 32321002 from the National Natural Science Foundation of China, the XPLORER PRIZE from the New Cornerstone Science Foundation, grant 2024YFC2511002 from the National Key Research and Development Program of China, and grant CHCMU-2024-XKDF-1001 from Clinical Research Project for the Summit Program of Children’s Hospital of Chongqing Medical University. J.Y. received grant SZSM202411012 supported by Sanming Project of Medicine in Shenzhen. D.M.S. received grants by Jeffrey Modell Foundation, Eli Lilly, Sobi, and the Samuel and Emma Winters Foundation, and Rheumatology Research Foundation. J.W received grants 82394420, 82394423, and 82402121 from the National Natural Science Foundation of China and grant 2023M733104 from China Postdoctoral Science Foundation. S.W. received grant 82402118 from the National Natural Science Foundation of China. L.G. received the grant LHDMY23H100005 from Joint Funds of the Zhejiang Provincial Natural Science Foundation of China. X.Y. received grants 82394420, 82394424, and 82471844 from the National Natural Science Foundation of China, the Hundred-Talent Program of Zhejiang University, grant 2021R01012 from the Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang and grant 2024Z221 from the Key Technology Breakthrough Program of Ningbo Sci-Tech Innovation YONGJIANG 2035. Y.L.L. received a grant from the Hong Kong Society for Relief of Disabled Children. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH). The contributions of the NIH authors are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services. Disclosure of potential conflict of interest: W. Gu and G. Yu are employees of Chigene (Beijing) Translational Medical Research Center Co Ltd and Beijing Quanpu Medical Laboratory Co Ltd. D. M. Schwartz has received consulting fees from Sobi and grant support from Sobi and Eli Lilly. The rest of the authors declare that they have no relevant conflicts of interest.
LinkOut - more resources
Full Text Sources
